These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 8477114)

  • 1. Subcutaneous absorption kinetics of two highly concentrated preparations of recombinant human growth hormone.
    Laursen T; Jørgensen JO; Susgaard S; Møller J; Christiansen JS
    Ann Pharmacother; 1993 Apr; 27(4):411-5. PubMed ID: 8477114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absorption kinetics of two highly concentrated preparations of growth hormone: 12 IU/ml compared to 56 IU/ml.
    Laursen T; Susgaard S; Jensen FS; Jørgensen JO; Christiansen JS
    Pharmacol Toxicol; 1994 Jan; 74(1):54-7. PubMed ID: 8159637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioavailability of recombinant human growth hormone in different concentrations and formulations.
    Vahl N; Jensen SB; Rasmussen MH; Susgaard S; Jørgensen JO; Christiansen JS; Rasmussen UF; Hilsted J
    Pharmacol Toxicol; 1996 Sep; 79(3):144-9. PubMed ID: 8884873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nasal absorption of growth hormone in normal subjects: studies with four different formulations.
    Laursen T; Ovesen P; Grandjean B; Jensen S; Jørgensen JO; Illum P; Christiansen JS
    Ann Pharmacother; 1994; 28(7-8):845-8. PubMed ID: 7949497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of concentration and injection volume on the bioavailability of subcutaneous growth hormone: comparison of administration by ordinary syringe and by injection pen.
    Blok GJ; van der Veen EA; Susgaard S; Larsen F
    Pharmacol Toxicol; 1991 May; 68(5):355-9. PubMed ID: 1946180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and metabolic effects of growth hormone injected subcutaneously in growth hormone deficient patients: thigh versus abdomen.
    Laursen T; Jørgensen JO; Christiansen JS
    Clin Endocrinol (Oxf); 1994 Mar; 40(3):373-8. PubMed ID: 7514513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous infusion versus daily injections of growth hormone (GH) for 4 weeks in GH-deficient patients.
    Laursen T; Jørgensen JO; Jakobsen G; Hansen BL; Christiansen JS
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2410-8. PubMed ID: 7543114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
    Chen C; Bujanover S; Kareht S; Rapoport AM
    Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The absorption profile and availability of a physiological subcutaneously administered dose of recombinant human growth hormone (GH) in adults with GH deficiency.
    Janssen YJ; Frölich M; Roelfsema F
    Br J Clin Pharmacol; 1999 Mar; 47(3):273-8. PubMed ID: 10215751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of subcutaneous injection site on absorption of human growth hormone: abdomen versus thigh.
    Beshyah SA; Anyaoku V; Niththyananthan R; Sharp P; Johnston DG
    Clin Endocrinol (Oxf); 1991 Nov; 35(5):409-12. PubMed ID: 1814654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioequivalence of Genotropin and Somatonorm.
    Wilton P; Widlund L; Guilbaud O
    Acta Paediatr Scand Suppl; 1987; 337():118-21. PubMed ID: 3481177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum growth hormone (GH) profiles after nasally administered GH in normal subjects and GH deficient patients.
    Møller J; Lauersen T; Mindeholm L; Hoelgaard A; Ovesen P; Jørgensen JO; Christiansen JS
    Clin Endocrinol (Oxf); 1994 Apr; 40(4):511-3. PubMed ID: 8187318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose-response studies with biosynthetic human growth hormone (GH) in GH-deficient patients.
    Jørgensen JO; Flyvbjerg A; Lauritzen T; Alberti KG; Orskov H; Christiansen JS
    J Clin Endocrinol Metab; 1988 Jul; 67(1):36-40. PubMed ID: 3288652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and pharmacodynamics of recombinant human growth hormone by subcutaneous jet- or needle-injection in patients with growth hormone deficiency.
    Houdijk EC; Herdes E; Delemarre-Van de Waal HA
    Acta Paediatr; 1997 Dec; 86(12):1301-7. PubMed ID: 9475305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intranasal Human Growth Hormone (hGH) Induces IGF-1 Levels Comparable With Subcutaneous Injection With Lower Systemic Exposure to hGH in Healthy Volunteers.
    Lewis AL; Jordan F; Patel T; Jeffery K; King G; Savage M; Shalet S; Illum L
    J Clin Endocrinol Metab; 2015 Nov; 100(11):4364-71. PubMed ID: 26425883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulsatile versus continuous intravenous administration of growth hormone (GH) in GH-deficient patients: effects on circulating insulin-like growth factor-I and metabolic indices.
    Jørgensen JO; Møller N; Lauritzen T; Christiansen JS
    J Clin Endocrinol Metab; 1990 Jun; 70(6):1616-23. PubMed ID: 2189886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative pharmacokinetics and pharmacodynamics of a new sustained-release growth hormone (GH), LB03002, versus daily GH in adults with GH deficiency.
    Bidlingmaier M; Kim J; Savoy C; Kim MJ; Ebrecht N; de la Motte S; Strasburger CJ
    J Clin Endocrinol Metab; 2006 Aug; 91(8):2926-30. PubMed ID: 16720652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioequivalence of subcutaneous injections of recombinant human follicle stimulating hormone (Puregon(R)) by Pen-injector and syringe.
    Voortman G; van de Post J; Schoemaker RC; van Gerven JM
    Hum Reprod; 1999 Jul; 14(7):1698-702. PubMed ID: 10402370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-term changes in serum insulin-like growth factors (IGF) and IGF binding protein 3 after different modes of intravenous growth hormone (GH) exposure in GH-deficient patients.
    Jørgensen JO; Blum WF; Møller N; Ranke MB; Christiansen JS
    J Clin Endocrinol Metab; 1991 Mar; 72(3):582-7. PubMed ID: 1705258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of growth hormone administration to mature miniature Brahman cattle treated with or without insulin on circulating concentrations of insulin-like growth factor-I and other metabolic hormones and metabolites.
    Chase CC; Elsasser TH; Spicer LJ; Riley DG; Lucy MC; Hammond AC; Olson TA; Coleman SW
    Domest Anim Endocrinol; 2011 Jul; 41(1):1-13. PubMed ID: 21420268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.